GSK plc (GSK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in GBP.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 15B 30B 45B Q4 '21: 24.7B Q4 '22: 29.3B Q4 '23: 30.3B Q4 '24: 31.4B Q4 '25: 32.7B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Gross Profit Annual

0 9B 18B 27B Q4 '21: 16.5B Q4 '22: 19.8B Q4 '23: 21.8B Q4 '24: 22.3B Q4 '25: 23.6B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Operating Income Annual

0 3B 6B 9B Q4 '21: 4.4B Q4 '22: 6.4B Q4 '23: 6.7B Q4 '24: 4B Q4 '25: 7.9B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Net Income Annual

0 6B 12B 18B Q4 '21: 5.1B Q4 '22: 15.6B Q4 '23: 5.3B Q4 '24: 3B Q4 '25: 6.3B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Cost of Revenue Annual

0 3.5B 7B 10.5B Q4 '21: 8.2B Q4 '22: 9.6B Q4 '23: 8.6B Q4 '24: 9B Q4 '25: 9B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Operating Cash Flow Annual

0 3B 6B 9B Q4 '21: 8B Q4 '22: 7.4B Q4 '23: 6.8B Q4 '24: 6.6B Q4 '25: 7.7B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Free Cash Flow Annual

0 2.5B 5B 7.5B Q4 '21: 7B Q4 '22: 6.3B Q4 '23: 5.5B Q4 '24: 5.2B Q4 '25: 6.4B Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.